Form 4: Shattuck Labs CEO Granted Stock Options
SEC Form 4 Filing
Shattuck Labs CEO, Taylor Schreiber, was granted stock options for 684,600 shares, vesting over a four-year period.
Summary
- Taylor Schreiber, the CEO of Shattuck Labs, was granted stock options to purchase 684,600 shares of the company's common stock.
- The options have an exercise price of $1.18 per share.
- The options vest over a period of four years, with one quarter vesting on January 28, 2026, and the remaining three quarters vesting in equal monthly installments through January 28, 2029.
- The vesting is contingent upon Mr. Schreiber's continued service to the company.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management and shareholder interests. There are no negative implications.
Positives
- The granting of stock options to the CEO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the CEO.
Risks
- The value of the options is dependent on the future performance of the company's stock price.
- If the CEO leaves the company before the options fully vest, he may forfeit some or all of the options.
Future Outlook
The stock options will vest over the next four years, contingent on the CEO's continued service.
Industry Context
Stock options are a common form of executive compensation in the biotechnology industry, used to incentivize performance and align management interests with shareholders.
Comparison to Industry Standards
- Stock option grants are a standard practice for executive compensation in the biotech industry.
- Vesting schedules of 3-5 years are typical for these types of grants.
- The specific terms of the grant, such as the exercise price and vesting schedule, are often tailored to the individual executive and the company's performance goals.
Stakeholder Impact
- Shareholders may view the stock option grant positively as it incentivizes the CEO to increase the company's value.
- Employees may see this as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 01/28/2025 | Date of the stock option grant. |
| 01/28/2026 | Date when one quarter of the stock options will vest. |
| 01/28/2029 | Date when the remaining stock options will be fully vested. |
| 01/28/2035 | Expiration date of the stock options. |
Keywords
stock options, executive compensation, vesting, Shattuck Labs, CEO, Taylor Schreiber
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.